Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Stroke. 2009 May 14;40(7):2382–2386. doi: 10.1161/STROKEAHA.109.548974

Table 1.

Subjects analyzed for hemorrhagic lesion volume

Subjects analyzed (n=46)
Age, mean ± standard deviation 74.8 ± 7.7
Female, n (%) 23 (50)
Hypertension, n (%) 26 (57)
Antiplatelet use, n (%) 22 (48)
Anticoagulant use, n (%) 4 (9)
Number of hemorrhagic lesions per scan,
median (25th, 75th percentiles)
11 (3, 26)

Age refers to time of MRI scan. Use of antiplatelet or anticoagulant agents refers to time of initial presentation with symptomatic intracerebral hemorrhage.